Loop diuretic treatment: time for new options
Keywords
loop diuretics
natriuresis
aldosterone
chronic heart failure
chronic kidney disease
Similar Articles
№1 / 2026
Zhmurov V.A., Ermakova P.A., Ermakova A.A., Zhmurov D.V., Tolstouhova N.V.
Using predictive models to improve the quality of medical care for patients with chronic kidney disease in primary care settings№4 / 2025
Zhmurov V.A., Vanuito E.Ya., Zhmurov D.V., Petrov I.M., Petrova Yu.A., Zhmurova E.A., Ermakova A.A., Ermakova P.A.
Predictors of chronic kidney disease progression in residents of the Far North№1 / 2025
Mikhailova L.V., Perepelitsa S.A., Struchkov S.T., Orlova Yu.A., Akchurina K.N.
Acute kidney injury in patients with COVID-19: severity of inflammatory response and risk of chronic kidney disease development№1 / 2026
Sokolova A.V., Dragunov D.O., Arutyunov G.P., Toporkova E.V., Suleimanova D.R., Abdusalyamova S.R., Skripachuk D.I.
Phase angle as an early marker of sarcopenia development№3 / 2025
Sokolova A.V., Dragunov D.O., Klimova A.V., Stafeeva E.A., Stafeev A.N., Golubev Ya.V., Shmigol T.A., Negrebetsky V.V., Arutyunov G.P.
Short-chain fatty acids as predictors of renal function decline in patients with sarcopenia and CHF


